Volume 27, Number 6—June 2021
CME ACTIVITY - Research
HIV Infection as Risk Factor for Death among Hospitalized Persons with Candidemia, South Africa, 2012–2017
Table 3
Variable | Summary aOR for death (95% CI) | Wald p value |
---|---|---|
HIV status | ||
Seronegative | Referent | |
Seropositive |
1.89 (1.38–2.60) |
<0.001 |
Age group, y | ||
<18 | Referent | |
18–44 | 2.55 (1.66–3.93) | <0.001 |
45–64 | 3.48 (2.21–5.49) | <0.001 |
>65 |
6.47 (3.61–11.61) |
<0.001 |
Sex | ||
F | Referent | |
M |
1.27 (0.95–1.70) |
0.11 |
Year | ||
2012 | Referent | |
2013 | 1.26 (0.72–2.19) | 0.42 |
2014 | 1.34 (0.67–2.68) | 0.40 |
2015 | 1.17 (0.58–2.33) | 0.66 |
2016 | 1.08 (0.63–1.86) | 0.77 |
2017 |
1.53 (0.90–2.61) |
0.12 |
ICU admission | ||
No | Referent | |
Yes |
1.70 (1.23–2.36) |
0.001 |
Receipt of systemic antifungal treatment | ||
No | Referent | |
Yes |
0.35 (0.25–0.48) |
<0.001 |
Candida species | ||
C. albicans | Referent | |
Other Candida spp. | 0.66 (0.49–0.89) | 0.006 |
*aOR, adjusted odds ratio; ICU, intensive care unit. Intra-cluster correlation coefficient = 0.03; likelihood ratio test for ρ = 0; p value = 0.003.
1Members of GERMS-SA are listed at the end of this article.
Page created: April 13, 2021
Page updated: May 19, 2021
Page reviewed: May 19, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.